Therapeutic intervention to MIMIC the effect of caloric restriction
OwnerMarco Chaconinventor
Life of this patent
Estimating the term…
Abstract
Methods are provided for promoting longevity and decreasing the incidence of aging associated pathologies (e.g., cancer) by the administration of one or more of the following LFFA: linoleic, oleic and palmitic acid. Secondary LFFA derived from this set, as well as their CoA derivatives and synthetic analogs, are effective also in promoting longevity and delaying the onset of age associated disorders. In addition, interventions including LFFA and CoA LFFA formulations are described which protect the organism from acute physical stress, tissue damage and hypoxia (either due to trauma or secondary to surgical procedures.
Claims18
1-10. (canceled)
A method of enhancing tolerance of hypoxia comprising:
- (a) selecting a mammal, and
- (b) administering to said mammal a long chain free fatty acid, its CoA adduct, non-hydrolyzable CoA analogs, derivatives which have greater half-lives, or combinations thereof in an amount sufficient to achieve a systemic level which serves to provide said mammal with a signal equivalent to that experienced during caloric restriction,
- whereby hypoxia tolerance is enhanced due to reduction in oxygen consumption.
A method improving the health of a mammal comprising:
- (a) selecting a mammal, and
- (b) administering to said mammal a long chain free fatty acid, its CoA adduct, non-hydrolyzable CoA analogs, derivatives which have greater half-lives, or combinations thereof in an amount sufficient to achieve a systemic level which serves to provide said mammal with a signal equivalent to that experienced during caloric restriction, and
- wherein said sufficient amount is determined by monitoring the inhibition of thyroid hormone receptor binding in vivo, inhibition of the Na/K ATPase and Ca ATPase in vivo, conservation of energy fuels, reduction in oxygen consumption, a decrease in core body temperature in said mammal, or activation of protective genes in vivo.
A method decreasing angiogenesis a mammal comprising:
- (a) selecting a mammal, and
- (b) administering to said mammal a long chain free fatty acid, its CoA adduct, non-hydrolyzable CoA analogs, derivatives which have greater half-lives, or combinations thereof in an amount sufficient to achieve a systemic level which serves to provide said mammal with a signal equivalent to that experienced during caloric restriction,
- whereby angiogenesis is decreased.
Dependencies are inferred from the claim text.